A Case Report with Severe Thrombocytopenia Induced by Axitinib

Axitinib is an oral, second-generation tyrosine kinase inhibitor that is selective for vascular endothelial growth factor receptors (VEGFR). This agent is approved as monotherapy or in combination with immune checkpoint inhibitors for the treatment of metastatic renal cell carcinoma. Axitinib is ass...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Hematol
Main Authors: Koksal, Ulkuhan I., Goffin, Janeiro Valle, Lewis, Brian, Sartor, Oliver A., Belyaeva, Elizaveta, Socola, Francisco, Barata, Pedro C.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7029294/
https://ncbi.nlm.nih.gov/pubmed/32089908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7520783
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados